Market Research Logo

Intellipharmaceutics International Inc (IPCI) - Financial and Strategic SWOT Analysis Review

Intellipharmaceutics International Inc (IPCI) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Intellipharmaceutics International Inc (Intellipharmaceutics) is a pharmaceutical company that researches, develops, manufactures, and commercializes novel and generic targeted oral solid dosage pharmaceuticals. The company develops its controlled-release and targeted-release oral solid dosage drugs based on its proprietary technology, Hypermatrix, a multidimensional controlled-release drug delivery platform. Its products and product candidates are used for the treatment of various indications, including neuropathic pain, attention deficit hyperactivity disorder (ADHD), schizophrenia, bipolar disorder, major depressive disorder, hypertension, type 2 diabetes, and chronic angina. It offers a comprehensive range of services, including pre-formulation studies, design, and development through to regulatory approval. Intellipharmaceutics’ is headquartered in Toronto, Ontario, Canada.

Intellipharmaceutics International Inc Key Recent Developments

Jul 16,2018: Intellipharmaceutics reports second quarter 2018 results
Jun 08,2018: Intellipharmaceutics Receives Anticipated Additional Staff Determination Letter from NASDAQ
Apr 27,2018: Intellipharmaceutics Files Appeal to Nasdaq Delisting Determination
Apr 16,2018: Intellipharmaceutics Reports First Quarter 2018 Results
Jan 24,2018: Intellipharmaceutics Provides Operational Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Intellipharmaceutics International Inc - Key Facts
Intellipharmaceutics International Inc - Key Employees
Intellipharmaceutics International Inc - Key Employee Biographies
Intellipharmaceutics International Inc - Major Products and Services
Intellipharmaceutics International Inc - History
Intellipharmaceutics International Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Intellipharmaceutics International Inc - Business Description
Intellipharmaceutics International Inc - Corporate Strategy
Intellipharmaceutics International Inc - SWOT Analysis
SWOT Analysis - Overview
Intellipharmaceutics International Inc - Strengths
Intellipharmaceutics International Inc - Weaknesses
Intellipharmaceutics International Inc - Opportunities
Intellipharmaceutics International Inc - Threats
Intellipharmaceutics International Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Intellipharmaceutics International Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jun 08, 2018: Intellipharmaceutics Receives Anticipated Additional Staff Determination Letter from NASDAQ
Apr 27, 2018: Intellipharmaceutics Files Appeal to Nasdaq Delisting Determination
Apr 27, 2018: Intellipharmaceutics Files Appeal to Nasdaq Delisting Determination
Jan 24, 2018: Intellipharmaceutics Provides Operational Update
Oct 10, 2017: Intellipharmaceutics Announces Third Quarter 2017 Results
Sep 01, 2017: Intellipharmaceutics Appoints New Chief Financial Officer
Aug 08, 2017: Intellipharmaceutics Announces Resignation of CFO
Jul 11, 2017: Intellipharmaceutics Announces Second Quarter 2017 Results
May 26, 2017: Intellipharmaceutics Files Preliminary Base Shelf Prospectus and Shelf Registration Statement to Replace Expiring Shelf Registration Statement
Apr 11, 2017: Intellipharmaceutics Announces First Quarter 2017 Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tabless
Intellipharmaceutics International Inc, Key Facts
Intellipharmaceutics International Inc, Key Employees
Intellipharmaceutics International Inc, Key Employee Biographies
Intellipharmaceutics International Inc, Major Products and Services
Intellipharmaceutics International Inc, History
Intellipharmaceutics International Inc, Subsidiaries
Intellipharmaceutics International Inc, Key Competitors
Intellipharmaceutics International Inc, Ratios based on current share price
Intellipharmaceutics International Inc, Annual Ratios
Intellipharmaceutics International Inc, Annual Ratios (Cont...1)
Intellipharmaceutics International Inc, Interim Ratios
Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Intellipharmaceutics International Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Intellipharmaceutics International Inc, Performance Chart (2013 - 2017)
Intellipharmaceutics International Inc, Ratio Charts
Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report